Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis
Alyxzandria M. Gaydosik, Connor J. Stonesifer, Tracy Tabib, Robert Lafyatis, Larisa J. Geskin, Patrizia Fuschiotti
Alyxzandria M. Gaydosik, Connor J. Stonesifer, Tracy Tabib, Robert Lafyatis, Larisa J. Geskin, Patrizia Fuschiotti
View: Text | PDF
Research Article Dermatology Oncology

The mycosis fungoides cutaneous microenvironment shapes dysfunctional cell trafficking, antitumor immunity, matrix interactions, and angiogenesis

  • Text
  • PDF
Abstract

Malignant T lymphocyte proliferation in mycosis fungoides (MF) is largely restricted to the skin, implying that malignant cells are dependent on their specific cutaneous tumor microenvironment (TME), including interactions with non-malignant immune and stromal cells, cytokines, and other immunomodulatory factors. To explore these interactions, we performed a comprehensive transcriptome analysis of the TME in advanced-stage MF skin tumors by single-cell RNA sequencing. Our analysis identified cell-type compositions, cellular functions, and cell-to-cell interactions in the MF TME that were distinct from those from healthy skin and benign dermatoses. While patterns of gene expression were common among patient samples, high transcriptional diversity was also observed in immune and stromal cells, with dynamic interactions and crosstalk between these cells and malignant T lymphocytes. This heterogeneity mapped to processes such as cell trafficking, matrix interactions, angiogenesis, immune functions, and metabolism that affect cancer cell growth, migration, and invasion, as well as antitumor immunity. By comprehensively characterizing the transcriptomes of immune and stromal cells within the cutaneous microenvironment of individual MF tumors, we have identified patterns of dysfunction common to all tumors that represent a resource for identifying candidates with therapeutic potential as well as patient-specific heterogeneity that has important implications for personalized disease management.

Authors

Alyxzandria M. Gaydosik, Connor J. Stonesifer, Tracy Tabib, Robert Lafyatis, Larisa J. Geskin, Patrizia Fuschiotti

×

Figure 2

Transcriptional profiles of macrophages and DCs from MF and HC skin samples.

Options: View larger image (or click on image) Download as PowerPoint
Transcriptional profiles of macrophages and DCs from MF and HC skin samp...
(A) Expression of macrophage and DC markers by AIF1+ cells from patient (n = 7) and HC (n = 9) skin samples. (B and C) Transcriptomes of 4,425 AIF1+ cells (1,115 from HC and 3,310 from MF skin samples) (B) revealed 9 discrete Louvain clusters (C) using Seurat (18, 19). (D) Bar plot showing the proportion of cells from each MF or HC sample within individual clusters. (E) Dot plot showing the proportion of cells and the scaled average gene expression of signature genes (n = 10) from the MF-specific clusters (2, 4, and 6) (C). Gene differential tests are described in Methods. (F) The differential gene lists were filtered by P value < 0.05 for significance and then run in Ingenuity Pathway Analysis (IPA, Qiagen) (78) for significant upregulated pathways. Highly significant examples of distinct pathways activated by the MF-specific clusters are shown. Pathways are represented by enrichment scores (–log P values) and selected by absolute z scores over 2 (78). (G and H) Multicolor immunofluorescence microscopy staining for FPR2 and FCN1 (G) or CLEC4C and LILRA4 (H) in advanced MF (n = 7) and HC (n = 4) skin samples. Representative examples are shown (×1,000). At right are higher-magnification examples of double-stained cells. DAPI stains nuclei.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts